Andere Sprachen Glenmark Pharmaceuticals Limited

Aktien

A0MU6U

INE935A01035

GLENMARK

Verzögert NSE India S.E. Andere Börsenplätze 13:58:32 07.06.2024			% 5 Tage	% 1. Jan.
1’194 ^INR	-1.30%		+2.91%	+39.84%

30.05.	Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day
29.05.	Assertio Therapeutics ernennt Brendan O'Grady zum Vorstandsvorsitzenden	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Glenmark Pharmaceuticals : Investor Day 2024	04.06.
Glenmark Pharmaceuticals : Investors Day 2024	30.05.
Assertio Therapeutics Names Brendan O'Grady as Chief Executive	29.05.
Glenmark Pharmaceuticals : Q4FY 2023-24	29.05.
INDIA STOCKS-Metal stocks lead Indian shares higher	28.05.
Glenmark Pharmaceuticals Widens Consolidated Net Loss in Fiscal Q4	27.05.
Glenmark Pharmaceuticals : Q4 FY 2023-24	27.05.
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports	27.05.
Glenmark Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2025	27.05.
Glenmark Pharmaceuticals : Pharma Reports Q4 FY2023-24 Financial results	24.05.
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	24.05.
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24.05.
Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24	24.05.
India's Sensex Ends Down, Nifty Up Ahead of National Poll Outcome	21.05.
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India	21.05.
Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%\|0.5%	20.05.
Glenmark Pharmaceuticals Receives ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%\|0.5%	17.05.
Glenmark Pharmaceuticals : receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%\|0.5%	17.05.
Glenmark Pharmaceuticals to Acquire 26% Stake in Renewable Energy Company	13.05.
Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer	03.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Glenmark Pharmaceuticals Limited

Aktien

A0MU6U

INE935A01035

GLENMARK

Andere Sprachen

Filter